ArticleArthritis research & therapy2018

Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study.

José Inciarte-Mundo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.